Soltani K. Alpha-fetoprotein: a review. J Investig Dermatol. 1979;72:211–3.

Article  CAS  PubMed  Google Scholar 

Tatarinov IuS. Detection of embryo-specific alpha-globulin in the blood sera of patients with primary liver tumour. Vop Med Khim. 1964;10:90–1.

CAS  Google Scholar 

Norgaard-Pedersen B, Albrechtsen R, Teilum G. Serum alpha-foetoprotein as a marker for endodermal sinus tumour (yolk sac tumour) or a vitelline component of “teratocarcinoma.” Acta Pathol Microbiol Scand A. 1975;83:573–89.

CAS  PubMed  Google Scholar 

McIntire KR, Waldmann TA, Moertel CG, Go VL. Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res. 1975;35:991–6.

CAS  PubMed  Google Scholar 

Chun H, Kwon SJ. Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer. 2011;11:23–30.

Article  PubMed  PubMed Central  Google Scholar 

Harada M, Tsujimoto H, Ichikura T, Nagata H, Ito N, Nomura S, et al. A case of a long-term survival achieved by surgical treatment and chemotherapy for late recurrence of AFP-producing gastric cancer. Surg Case Rep. 2019;5:106.

Article  PubMed  PubMed Central  Google Scholar 

Tanaka K, Fujiya M, Ijiri M, Takahashi K, Ando K, Nomura Y, et al. A case of alpha-fetoprotein-producing adenocarcinoma of the esophagogastric junction in which long-term survival was achieved by means of individualized multidisciplinary therapy. J Gastrointest Cancer. 2019;50:617–20.

Article  PubMed  Google Scholar 

Nakao S, Nakata B, Tendo M, Kuroda K, Hori T, Inaba M, et al. Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report. BMC Surg. 2015;15:5.

Article  PubMed  PubMed Central  Google Scholar 

Chang YC, Nagasue N, Kohno H, Taniura H, Uchida M, Yamanoi A, et al. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol. 1990;85:1480–5.

CAS  PubMed  Google Scholar 

Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol. 1992;87:321–5.

CAS  PubMed  Google Scholar 

Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg. 2002;19:359–65 (discussion 365).

Article  CAS  PubMed  Google Scholar 

Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S. AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology. 2003;65:95–101.

Article  CAS  PubMed  Google Scholar 

Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology. 2004;66:445–9.

Article  CAS  PubMed  Google Scholar 

Ishigami S, Natsugoe S, Nakashima H, Tokuda K, Nakajo A, Okumura H, et al. Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology. 2006;53:338–41.

PubMed  Google Scholar 

Liu X, Cheng Y, Sheng W, Lu H, Xu Y, Long Z, et al. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases. J Surg Oncol. 2010;102:249–55.

Article  PubMed  Google Scholar 

Inoue M, Sano T, Kuchiba A, Taniguchi H, Fukagawa T, Katai H. Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer. Br J Surg. 2010;97:1056–61.

Article  CAS  PubMed  Google Scholar 

Liu X, Sheng W, Wang Y. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer. J Surg Oncol. 2012;106:299–303.

Article  PubMed  Google Scholar 

Li XD, Wu CP, Ji M, Wu J, Lu B, Shi HB, et al. Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China. World J Surg Oncol. 2013;11:246.

Article  PubMed  PubMed Central  Google Scholar 

Hirajima S, Komatsu S, Ichikawa D, Kubota T, Okamoto K, Shiozaki A, et al. Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer. World J Gastroenterol. 2013;19:6055–61.

Article  PubMed  PubMed Central  Google Scholar 

Lin HJ, Hsieh YH, Fang WL, Huang H, Li AF. Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer. Curr Oncol. 2014;21:e394–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Qu H, Jian M, Sun G, He Q. High level of serum AFP is an independent negative prognostic factor in gastric cancer. Int J Biol Mark. 2015;30:e387–93.

Article  CAS  Google Scholar 

Wang D, Li C, Xu Y, Xing Y, Qu L, Guo Y, et al. Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients. Int J Clin Exp Pathol. 2015;8:6345–55.

PubMed  PubMed Central  Google Scholar 

Reim D, Choi YS, Yoon HM, Park B, Eom BW, Kook MC, et al. Alpha-fetoprotein is a significant prognostic factor for gastric cancer: results from a propensity score matching analysis after curative resection. Eur J Surg Oncol. 2017;43:1542–9.

Article  CAS  PubMed  Google Scholar 

He R, Yang Q, Dong X, Wang Y, Zhang W, Shen L, et al. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer. Oncotarget. 2017;8:23817–30.

Article  PubMed  PubMed Central  Google Scholar 

Bozkaya Y, Demirci NS, Kurtipek A, Erdem GU, Ozdemir NY, Zengin N. Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma. Mol Clin Oncol. 2017;7:267–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bozkaya Y, Doğan M, Yazıcı O, Erdem GU, Demirci NS, Zengin N. The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma. Bosn J Basic Med Sci. 2017;17:138–43.

CAS  PubMed  PubMed Central  Google Scholar 

Wang YK, Shen L, Jiao X, Zhang XT. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP. World J Gastroenterol. 2018;24:266–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu D, Li B, Yan B, Liu L, Jia Y, Wang Y, et al. The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases. Int J Clin Exp Pathol. 2020;13:2439–46.

PubMed  PubMed Central  Google Scholar 

Wang R, Li J, Xu D, Li R, Gong P. Dynamic change in serum alpha-fetoprotein level predicts treatment response and prognosis of alpha-fetoprotein-producing gastric cancer. Medicine (Baltimore). 2020;99: e23326.

Article  CAS  PubMed  Google Scholar 

Zhan Z, Chen B, Yu J, Zheng J, Zeng Y, Sun M, et al. Elevated serum alpha-fetoprotein is a significant prognostic factor for patients with gastric cancer: results based on a large-scale retrospective study. Front Oncol. 2022;12: 901061.

Article  PubMed  PubMed Central  Google Scholar 

Eom BW, Lee JH, Lee JS, Kim MJ, Ryu KW, Choi IJ, et al. Survival analysis of gastric cancer patients with tumor thrombus in the portal vein. J Surg Oncol. 2012;105:310–5.

Article  PubMed  Google Scholar 

Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390:2461–71.

Article  CAS  PubMed  Google Scholar 

Makiyama A, Arimizu K, Hirano G, Makiyama C, Matsushita Y, Shirakawa T, et al. Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer. Gastric Cancer. 2018;21:464–72.

Article  CAS  PubMed  Google Scholar 

Harris SJ, Brown J, Lopez J, Yap TA. Immuno-oncology combinations: raising the tail of the survival curve. Cancer Biol Med. 2016;13(2):171–93.

Article  CAS  PubMed  PubMed Central  Google Scholar